Corrigendum to "A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer" [Gynecologic Oncology 163 (2021) 481-489].

Overview

cited authors

Manyam, Madhavi; Stephens, Amanda J; Kennard, Jessica A; LeBlanc, Jane; Ahmad, Sarfraz; Kendrick, James E; Holloway, Robert W

authors

Ahmad, Sarfraz, PhD, FAACC; FABAP
Holloway, Robert W., MD
Kendrick, James Erasmus IV, MD, FACOG

Publication Date

May 1, 2022

webpage

Web of Science

published in

Gynecologic oncology Journal

Additional Document Info

start page

volume

issue

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.